Increased Colorectal Cancer Incidence in Obligate Carriers of Heterozygous Mutations in MUTYH
Background & Aims
MUTYH-associated polyposis (MAP) is an autosomal recessive disorder caused by mutations in the MUTYH gene. Patients with MAP are at extremely high risk of colorectal cancer, but the risks of colorectal and other cancers in heterozygous carriers of a single MUTYH mutation are uncertain. We performed a retrospective study of cancer incidence and causes of death among obligate MUTYH heterozygote individuals.
Methods
MAP index cases were identified from polyposis registers in Germany, The Netherlands, and the United Kingdom. Cancer incidence, cancer mortality, and all-cause mortality data were collected from 347 parents of unrelated MAP index cases and the spouses of 3 index cases who were also found to be heterozygous for single MUTYH mutations. These data were compared with appropriate national sex-, age-, and period-specific population data to obtain standardized mortality ratios (SMR) and standardized incidence ratios (SIR).
Results
There was a 2-fold increase in the incidence of colorectal cancer among parents of MAP cases, compared with the general population (SIR, 2.12; 95% confidence interval [CI]: 1.30–3.28). Their colorectal cancer mortality was not increased significantly (SMR, 1.02; 95% CI: 0.41–2.10) nor was overall cancer risk (SIR, 0.92; 95% CI: 0.70–1.18), cancer mortality (SMR, 1.12; 95% CI: 0.83–1.48), or overall mortality (SMR, 0.94; 95% CI: 0.80–1.08).
Conclusions
The risk of colorectal cancer in heterozygous carriers of single MUTYH mutations who are relatives of patients with MAP is comparable with that of first-degree relatives of patients with sporadic colorectal cancer. Screening measures should be based on this modest increase in risk.
Abbreviations used in this paper: CRC, colorectal cancer, MAP, MUTYH-associated polyposis, SMR, standardized mortality ratio, SIR, standardized incidence ratio
This article has an accompanying continuing medical education activity on page 725. Learning Objective: Upon completion of this exam, successful learners will be able to identify the main colorectal phenotypic features and genetic characteristics of MUTYH-associated polyposis.
Conflicts of interest The authors disclose the following: J. R. Sampson has previously made intellectual property rights applications in relation to MUTYH sequence variants. The remaining authors disclose no conflicts.
Funding Supported in part by Cancer Research Wales, the Wales Office of Research and Development through the Wales Gene Park, German Cancer Aid (Deutsche Krebshilfe e.V. Bonn, grant No. 106244) and the Dutch Digestive Diseases Foundation (grant No. MWO 0355).
PII: S0016-5085(09)00560-5
doi:10.1053/j.gastro.2009.04.047
© 2009 AGA Institute. Published by Elsevier Inc. All rights reserved.
Refers to article:
- Continuing Medical Education Exam 2, August 2009 , 26 June 2009


